Advertisement

Archives of Osteoporosis

, 13:112 | Cite as

Association between polycyclic aromatic hydrocarbons and osteoporosis: data from NHANES, 2005–2014

  • Wenhou Duan
  • Xin Meng
  • Yanxin Sun
  • Chongqi Jia
Original Article
  • 24 Downloads

Abstract

Summary

The association between osteoporosis and polycyclic aromatic hydrocarbons was not clear. However, recent studies showed that both osteoporosis and polycyclic aromatic hydrocarbons were associated with reactive oxygen species. So we presumed that polycyclic aromatic hydrocarbons were associated with increased odds of osteoporosis. We found 3-hydroxyfluorene was associated with decreased odds of osteoporosis, while 2-hydroxyfluorene was associated with increased odds of osteoporosis.

Purpose

Previous studies showed that polycyclic aromatic hydrocarbons were involved in the production of reactive oxygen species that played an important role in illness. Other studies demonstrated that the reactive oxygen species might play a role in occurrence of osteoporosis. However, the association between polycyclic aromatic hydrocarbons and osteoporosis was not clear. Therefore, we conducted a study to investigate the relationship between polycyclic aromatic hydrocarbons and osteoporosis.

Methods

A total of 3053 individuals aged 50 years or older were drawn from National Health and Nutritional Examination Survey, 2005–2014. Eight polycyclic aromatic hydrocarbons metabolites (1-hydroxynaphthalene, 2-hydroxynaphthalene, 2-hydroxyfluorene, 3-hydroxyfluorene, 1-hydroxyphenanthrene, 2-hydroxyphenanthrene, and 3-hydroxyphenanthrene and 1-hydroxypyrene) were examined to represent exposure of polycyclic aromatic hydrocarbons in the body. Weighted percentage and weighted mean were used to describe classified variable and continuous variable, respectively. We used weighted logistic regression to estimate the association of polycyclic aromatic hydrocarbons and osteoporosis.

Results

Five hundred seventy-seven (18.9%) osteoporosis patients were included. Among the eight polycyclic aromatic hydrocarbons metabolites, 3-hydroxyfluorene was associated with decreased odds of osteoporosis after controlling socio-demographic status, body mass index, alcohol, previous fracture, parental fracture, glucocorticoid use, dietary calcium intake, smoking, and other polycyclic aromatic hydrocarbons metabolites (OR = 0.63, 95%CI 0.41–0.98). 2-hydroxyfluorene (OR = 1.87, 95%CI 1.07–3.29) was associated with increased odds of osteoporosis. In the nonsmoking group, we found the association of osteoporosis with 2-hydroxyfluorene (OR = 2.56, 95%CI 1.10–5.96) and 3-hydroxyfluorene (OR = 0.41, 95%CI 0.22–0.77) still exists.

Conclusion

Our study found that 3-hydroxyfluorene was associated with decreased odd of osteoporosis, while 2-hydroxyfluorene was associated with increased odds of osteoporosis. Our study was a cross-sectional study, therefore cohort studies or experimental studies about association of PAH and osteoporosis is needed.

Keywords

Polycyclic aromatic hydrocarbons Osteoporosis 2-hydroxyfluorene 3-hydroxyfluorene 

Notes

Acknowledgments

My deepest gratitude goes first and foremost to Professor Jia Chongqi for his constant encouragement and guidance. Second, we thank the National Center for Health Statistics (NCHS) for providing the datasets of National Health and Nutrition Examination Survey (NHANES). Third, I would like to express my heartfelt gratitude to my fellow classmates, who give me help in modifying the paper. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

None.

References

  1. 1.
    listed Na (2001) NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, march 7-29, 2000: highlights of the conference. South Med J 94(6):569–573Google Scholar
  2. 2.
    International Osteoporosis Foundation (2013) Osteoporosis - Incidence and burden. [cited 2018 March]; Available from: http://www.iofbonehealth.org/facts-statistics
  3. 3.
    Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation between fractures and mortality: results from the Canadian multicentre osteoporosis study. Cmaj 181(5):265–271CrossRefGoogle Scholar
  4. 4.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465–475CrossRefGoogle Scholar
  5. 5.
    National Osteoporosis Foundation What is osteoporosis and what causes it? [cited 2014 22 July ]; Available from: http://nof.org/articles/7
  6. 6.
    Kanis, J.A., Assessment of osteoporosis at the primary health care level. 2007Google Scholar
  7. 7.
    Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 28(5):395–409CrossRefGoogle Scholar
  8. 8.
    Department of Health and Human Services, U.S. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004. [cited 2017 5 April]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK45513/
  9. 9.
    Freeman DJ, Cattell FCR (1990) Woodburning as a source of atmospheric polycyclic aromatic hydrocarbons. Environ Sci Technol 65(3–4):235–242Google Scholar
  10. 10.
    Galarneau E (2008) Source specificity and atmospheric processing of airborne PAHs: implications for source apportionment. Atmos Environ 42(35):8139–8149CrossRefGoogle Scholar
  11. 11.
    DeMarini DM (2004) Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 567(2–3):447–474CrossRefGoogle Scholar
  12. 12.
    Eom SY, Yim DH, Moon SI, Youn JW, Kwon HJ, Oh HC, Yang JJ, Park SK, Yoo KY, Kim HS, Lee KS, Chang SH, Kim YD, Kang JW, Kim H (2013) Polycyclic aromatic hydrocarbon-induced oxidative stress, antioxidant capacity, and the risk of lung cancer: a pilot nested case-control study. Anticancer Res 33(8):3089–3097PubMedGoogle Scholar
  13. 13.
    Osgood RS, Upham BL, Hill T 3rd, Helms KL, Velmurugan K, Babica P, Bauer AK (2014) Polycyclic aromatic hydrocarbon-induced signaling events relevant to inflammation and tumorigenesis in lung cells are dependent on molecular structure. PLoS One 8(6):e65150CrossRefGoogle Scholar
  14. 14.
    Fu PP, Xia Q, Sun X, Yu H (2012) Phototoxicity and environmental transformation of polycyclic aromatic hydrocarbons (PAHs)-light-induced reactive oxygen species, lipid peroxidation, and DNA damage. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 30(1):1–41CrossRefGoogle Scholar
  15. 15.
    Henkler F, Stolpmann K, Luch A (2012) Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses. Exs 101:107–131PubMedGoogle Scholar
  16. 16.
    Xia Q, Yin JJ, Zhao Y, Wu YS, Wang YQ, Ma L, Chen S, Sun X, Fu P, Yu H (2013) UVA photoirradiation of nitro-polycyclic aromatic hydrocarbons-induction of reactive oxygen species and formation of lipid peroxides. Int J Environ Res Public Health 10(3):1062–1084CrossRefGoogle Scholar
  17. 17.
    About the National Health and Nutrition Examination Survey. Available from: https://www.cdc.gov/nchs/nhanes/about_nhanes.htm
  18. 18.
    Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE, Lindsay R, Nana AD, Orwoll ES, Saag K, Silverman S, Watts NB (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25(5):1439–1443CrossRefGoogle Scholar
  19. 19.
    Wright NC, Saag KG, Dawson-Hughes B, Khosla S, Siris ES (2017) The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int 28(4):1225–1232CrossRefGoogle Scholar
  20. 20.
    National Center for Health Statistics. National Health and Nutrition Examination Survey: Plan and Operations, 1999–2010. Available from: https://wwwn.cdc.gov/nchs/data/series/sr01_056.pdf
  21. 21.
    Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12(11):1761–1768CrossRefGoogle Scholar
  22. 22.
    Jung KJ, Chung CY, Park MS, Kwon SS, Moon SY, Lee IH, Kim KH, Lee KM (2016) Different reference BMDs affect the prevalence of osteoporosis. J Bone Miner Metab 34(3):347–353CrossRefGoogle Scholar
  23. 23.
    Dawson-Hughes B, Looker AC, Tosteson ANA, Johansson H, Kanis JA, Melton LJ (2012) The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int 23(3):811–820CrossRefGoogle Scholar
  24. 24.
    Cosman F, de Beur SJ, LeBoff M, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381CrossRefGoogle Scholar
  25. 25.
    The Centers for Disease Control and Prevention (2006) Laboratory Procedure Manual. [cited 2006 10/03]; Available from: https://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l31pah_c_met.pdf
  26. 26.
    The Centers for Disease Control and Prevention Laboratory Procedure Manual. Available from: https://www.cdc.gov/Nchs/Data/Nhanes/Nhanes_13_14/PAH_H_MET_Aromatic_Hydrocarbons.pdf
  27. 27.
    Charles J.. Rothwell, J.H.M., Kathryn S.Porter. (2013) National Health and Nutrition Examination Survey: Estimation Procedures, 2007–2010. [cited 2013 August]; Available from: https://wwwn.cdc.gov/nchs/data/series/sr02_159.pdf
  28. 28.
    Hu H, Kan H, Kearney GD, Xu X (2015) Associations between exposure to polycyclic aromatic hydrocarbons and glucose homeostasis as well as metabolic syndrome in nondiabetic adults. Sci Total Environ 505:56–64CrossRefGoogle Scholar
  29. 29.
    Xu X, Hu H, Kearney GD, Kan H, Sheps DS (2013) Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States. Sci Total Environ 461-462:341–347CrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2018

Authors and Affiliations

  • Wenhou Duan
    • 1
  • Xin Meng
    • 1
  • Yanxin Sun
    • 1
  • Chongqi Jia
    • 1
  1. 1.Department of Epidemiology and BiostatisticsShandong UniversityJinanPeople’s Republic of China

Personalised recommendations